BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Diagnosis
42 results:

  • 1. Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94).
    Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    World J Urol; 2024 Mar; 42(1):152. PubMed ID: 38483586
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Non-medical interventions to enhance return to work for people with cancer.
    de Boer AG; Tamminga SJ; Boschman JS; Hoving JL
    Cochrane Database Syst Rev; 2024 Mar; 3(3):CD007569. PubMed ID: 38441440
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hyperthyroidism and the risk of non-thyroid cancer: a Danish register-based long-term follow-up study.
    Riis T; Bonnema SJ; Brix TH; Folkestad L
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38367342
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Application of dynamic contrast enhanced status in multiparametric magnetic resonance imaging for prostatic cancer with PI-RADS 4 lesion].
    Yuan CW; Li R; Li ZH; Liu Y; Shan GZ; Li XS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):838-842. PubMed ID: 37807737
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A nomogram based on biparametric magnetic resonance imaging for detection of clinically significant prostate cancer in biopsy-naïve patients.
    Hu B; Zhang H; Zhang Y; Jin Y
    Cancer Imaging; 2023 Sep; 23(1):82. PubMed ID: 37667393
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy.
    Wang Y; Zhu Y; Fan L; Liu J; Pan J; Xue W
    Int Urol Nephrol; 2023 Jun; 55(6):1447-1452. PubMed ID: 37017821
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer.
    Kim KJ; Kim KJ; Choi J; Kim NH; Kim SG
    J Natl Cancer Inst; 2023 Jun; 115(6):695-702. PubMed ID: 36821433
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection and genitourinary cancers: A case-control study.
    Angelidakis G; Mahale P; Jonasch E; Jiang Y; Torres HA
    Semin Oncol; 2020; 47(2-3):165-167. PubMed ID: 32507667
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
    J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With cancer.
    Seow H; Tanuseputro P; Barbera L; Earle C; Guthrie D; Isenberg S; Juergens R; Myers J; Brouwers M; Sutradhar R
    JAMA Netw Open; 2020 Apr; 3(4):e201768. PubMed ID: 32236529
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is the level of diffusion restriction in celiac and cervico-thoracic sympathetic ganglia helpful in their proper recognition on PSMA ligand PET/MR?
    Bialek EJ; Malkowski B
    Nuklearmedizin; 2020 Aug; 59(4):300-307. PubMed ID: 32005043
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Delays in prostate cancer care within a hospital network in Victoria, Australia.
    Qu LG; Nzenza T; McMillan K; Sengupta S
    ANZ J Surg; 2019 Dec; 89(12):1599-1604. PubMed ID: 31786815
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of key genes in prostate cancer gene expression profile by bioinformatics.
    Lu W; Ding Z
    Andrologia; 2019 Feb; 51(1):e13169. PubMed ID: 30311263
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Digital Rectal Examination for prostate cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.
    Naji L; Randhawa H; Sohani Z; Dennis B; Lautenbach D; Kavanagh O; Bawor M; Banfield L; Profetto J
    Ann Fam Med; 2018 Mar; 16(2):149-154. PubMed ID: 29531107
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Secondary tumors of the GI tract: origin, histology, and endoscopic findings.
    Gilg MM; Gröchenig HP; Schlemmer A; Eherer A; Högenauer C; Langner C
    Gastrointest Endosc; 2018 Jul; 88(1):151-158.e1. PubMed ID: 29476848
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association between age-related reductions in testosterone and risk of prostate cancer-An analysis of patients' data with prostatic diseases.
    Wang K; Chen X; Bird VY; Gerke TA; Manini TM; Prosperi M
    Int J Cancer; 2017 Nov; 141(9):1783-1793. PubMed ID: 28699177
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. prostate biopsy handling: special tiss1ue embedding technique with sponges affects the yield of prostatic tissue available for microscopic examination.
    Sitpura K; Salmo E
    Gulf J Oncolog; 2016 May; 1(21):46-8. PubMed ID: 27250887
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Cost Prediction Using a Survival Grouping Algorithm: An Application to Incident prostate cancer Cases.
    Onukwugha E; Qi R; Jayasekera J; Zhou S
    Pharmacoeconomics; 2016 Feb; 34(2):207-16. PubMed ID: 26714688
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. 2015 Alzheimer's disease facts and figures.
    Alzheimer’s Association
    Alzheimers Dement; 2015 Mar; 11(3):332-84. PubMed ID: 25984581
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.